STAT Plus: ‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation
EMILIE PICKERING FOR STAT
CEOs from Bluebird Bio, Sage Therapeutics, and Turning Point Therapeutics owned up to biopharma's bad reputation at a STAT Summit panel.
No hay comentarios:
Publicar un comentario